drug prices

COMMENTARY

Dangerous care delays ahead if more insurers implement “white bagging” policies

BY: - December 15, 2021

Consider the following scenario: A cancer patient comes into a community oncology clinic for their regularly scheduled chemotherapy treatment. After concluding the pre-treatment evaluation, the oncologist determines that the patient’s dose should be adjusted. Perhaps they need a higher dose than what we previously administered — a fairly common occurrence in the world of cancer […]

Despite restraints, Democrats’ drug pricing plan could still aid consumers

BY: - November 8, 2021

By Michael McAuliff, Kaiser Health News The Medicare prescription drug pricing plan Democrats unveiled this week is not nearly as ambitious as many lawmakers sought, but they and drug policy experts say the provisions crack open the door to reforms that could have dramatic effects. Tamping down drug expenses has been a longtime rallying cry for consumers beset […]

Biden administration announces “comprehensive” plan to fix high drug prices

BY: - September 13, 2021

The U.S. Department of Health and Human Services last week issued its plan to address high drug prices as part of President Joe Biden’s push to take on anticompetitive practices across the economy. But while it addressed in detail abusive practices by drugmakers, it was a lot more superficial about the practices of much-larger corporations […]

COMMENTARY

2+2=? Senate uses murky math as it shelves drug pricing rule to fund infrastructure

BY: - August 6, 2021

By Michael McAuliff, Kaiser Health News The Senate’s release of its bipartisan infrastructure plan signals that lawmakers are poised to throw former President Donald Trump’s belated bid to lower Medicare drug prices under the bus — not to mention trains, bridges, tunnels and broadband connections. That’s because the massive spending bill is the first of […]

Eleven generic versions of an HIV drug rush onto the market… and list prices go up

BY: - May 28, 2021

The health care system is supposed to incentivize the development of wonder drugs and then apply market forces to squeeze prices to a minimum. But a new report shows how at least for one drug, incentivizing is working a lot better than price-squeezing. At least when insurance is involved. For example, Blueberry Pharmacy in the […]

COMMENTARY

To fix drug costs, stop Big Pharma price-gouging and tax-dodging

BY: - May 27, 2021

By Hannah Hendrix, American Medical Student Association I’m studying at The Ohio State University to become a doctor because I want to help people. Unfortunately, far too many Americans today are confronting skyrocketing prescription drug costs that prevent them from following their doctor’s advice because they can’t afford treatments they need. Drug prices are rising […]